newcleo has announced its incorporation with the closing of a USD 118 million initial capital raising and the acquisition of Hydromine Nuclear Energy S.a r.l. (HNE). newcleo's disruptive approach is based on the innovative application of well-developed technologies, including, (1) Lead Fast Reactors (LFRs), which utilise lead as a coolant rather than water or sodium, (2) Accelerator Driven Systems (ADSs), based on coupling a sub-critical reactor with a particle accelerator and (3) the use of natural thorium fuel.

The application of these technologies has the potential to:

1. dramatically decrease the volume of radioactive waste produced, while eliminating the need of a geological repository for transuranic elements;

2. much more effective use of existing uranium fuel, while moving toward the use of natural thorium;

3. avoid nuclear accidents as the reactor core remains at all times, sub-critical, and the nuclear cascade can be interrupted instantly by switching off the accelerator.

Nobel laureate Carlo Rubbia, who invented ADSs while he was Director General at CERN (the European Organization for Nuclear Research), shares newcleo's vision for clean nuclear energy and is personally supportive of newcleo's mission.

newcleo's core leadership team brings a decades-long track record in both scientific and entrepreneurial achievements: Stefano Buono as CEO, the former founder of the NASDAQ-listed Advanced Accelerator Applications (sold to Novartis in 2018); Luciano Cinotti as Chief Scientific Officer; Elisabeth Rizzotti as Chief Operating Officer and CEO of the Italian research operations.

With headquarters in London, an ideal base for global operations requiring connectivity and an international workforce, newcleo will initially base its research team in Turin, Italy. There, over 100 'energy innovators' will work under the oversight of a Scientific Committee with extensive nuclear energy experience.

newcleo's first key development will be the LFR 'Re-Act' project; a liquid lead modular micro-reactor with significant commercial applications, for example in shipping. This prototype will be the realisation of a concept known at the International Atomic Energy Agency (IAEA) as the LFR-TL-X project1. Within the next five years, the company intends to finalise the design and realise a full-scale non-nuclear industrial prototype in collaboration with ENEA (Italian National Agency for New Technologies, Energy and Sustainable Economic Development), that also shares one of newcleo's patents.

As demonstrated by the successful acquisition of HNE, newcleo's strategy is to actively pursue all the necessary M&A transactions and partnerships across the globe among energy sector players, institutions, academia and investors, as well as ad hoc acquisitions to rapidly bring to market its projects and create a new industrial standard.

The capital raising has gathered strong international interest led by several visionary individuals and also supported by some institutional investors, including New York-based Exor Seeds, and Turin-based LIFTT and Club degli Investitori.

Remarking on launch day, Stefano Buono, newcleo CEO, commented: "In 1994, I started to work with Carlo Rubbia at CERN on approaches to producing safe, renewable and clean energy. I realised then that it would be possible to disrupt the energy sector with a scalable industrial application of our scientific findings. Having created Advanced Accelerator Applications as a ground-breaking company in theragnostic nuclear medicine, I have founded newcleo with the same vision: to bring existing nuclear innovative technologies to market for the benefit of the whole world. 'Futurable Energy' perfectly summarises what we intend to do: to develop a new, sustainable, and completely safe way of extracting energy from nuclei that will offer the planet zero emissions, radical reductions in nuclear waste and a material decrease in global warming. I feel the scientific ambition and moral obligation to make this technology a reality."

Related Links
newcleo
Nuclear Power News - Nuclear Science, Nuclear Technology
Powering The World in the 21st Century at Energy-Daily.com

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Framatome and BBF achieve testing milestone for medical sterilization transport system
Kernen, Germany (SPX) Aug 16, 2021
Framatome recently completed the factory acceptance test of an advanced transport system for BBF Sterilisationsservice GmbH's sterilization facility in Kernen, Germany. The self-conveyor transport system ensures medical products to be sterilized move carefully in containers through the irradiation process. The system is based on walking-beam technology and represents the first time that technology will be used in the process of sterilizing medical products and pharmaceuticals. "Achieving this impo ... read more